Molecular Partners AG: Molecular Partners to Present at Upcoming Healthcare Investor Conferences
Molecular Partners AG: Molecular Partners to Present at Upcoming Healthcare Investor Conferences ZURICH-SCHLIEREN, SWITZERLAND / ACCESSWIRE / January 6, 2021 / Molecular Partners AG (SIX:MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin® therapeutics, today announced that its Chief Executive Officer, Patrick Amstutz, Ph.D., will present at or attend several upcoming virtual healthcare investor events in January, 2021. Conference Presentation Details: Date/Time: Monday, January 11, 2021 at 6:00 a.m. ET (12:00 p.m. CET) Event: Baader H...